This inventor holds 6 USPTO granted patents and 1 EPO patent. Top assignees: The University of Texas System, Wyeth Holdings Corporation, Other. Active years: 2001-2009.
Company Filing History:
4 out of 5,627 
2 out of 113 
2 out of 834,350 Years Active: 2001-2009
Title: The Innovations of Ross A. Fredenburg
Introduction
Ross A. Fredenburg is a notable inventor based in Rochester, NY (US). He has made significant contributions to the field of biotechnology, particularly in the study of proteins related to Moraxella catarrhalis. With a total of 6 patents to his name, Fredenburg's work has implications for both diagnostic and therapeutic methods.
Latest Patents
One of Fredenburg's latest patents involves the UspA2 nucleic acid of Moraxella catarrhalis. This invention discloses the existence of two novel proteins, UspA1 and UspA2, along with their respective genes, uspA1 and uspA2. Each protein contains a conserved region and an epitope recognized by the monoclonal antibody MAb 17C7. These proteins may aggregate to form a very high molecular weight form of the UspA antigen, which is greater than 200 kDa. The patent also covers compositions and methods for the treatment and study of related conditions.
Career Highlights
Fredenburg has worked with prominent organizations, including the University of Texas System and Wyeth Holdings Corporation. His experience in these institutions has allowed him to advance his research and contribute to the scientific community.
Collaborations
Some of Fredenburg's notable coworkers include Leslie D. Cope and Michael J. Fiske. Their collaborative efforts have likely enriched the research environment and fostered innovation.
Conclusion
Ross A. Fredenburg's contributions to biotechnology and his innovative patents highlight his role as a significant inventor in the field. His work continues to influence diagnostic and therapeutic methods, showcasing the importance of research and collaboration in scientific advancements.